AI assistant
Biohit Oyj — Director's Dealing 2017
Mar 1, 2017
3304_rns_2017-03-01_a793e0a5-b151-4a62-ae59-32b16ffac5a5.html
Director's Dealing
Open in viewerOpens in your device viewer
Biohit Oyj - Managers' Transactions
Biohit Oyj - Managers' Transactions
Biohit Oyj - Managers' Transactions, March 1, 2017 at 11:50 am local time (EET)
Person subject to the notification requirement
Name: Euroclone Spa Legal Person
Position: Closely associated person
Person discharging managerial responsibilities in issuer
Name: Aiolfi, Franco
Position: Member of the Board/Deputy member
Initial Notification
Reference number: 74370089ATTSNBXJVT29_20170227134828_12
Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29
Transaction details
Transaction date: 2017-02-24
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Exercise (Rights, Put and Call Options)
Instrument: Share
ISIN: FI0009005482
Volume: 475
Unit price: 5,56000 Euro
Volume: 458
Unit price: 5,57000 Euro
Volume: 1000
Unit price: 5,56000 Euro
Volume: 200
Unit price: 5,55000 Euro
Volume: 200
Unit price: 5,56000 Euro
Volume: 100
Unit price: 5,57000 Euro
Volume: 1500
Unit price: 5,57000 Euro
Volume: 200
Unit price: 5,55000 Euro
Volume: 150
Unit price: 5,55000 Euro
Volume: 62
Unit price: 5,55000 Euro
Volume: 200
Unit price: 5,55000 Euro
Volume: 69
Unit price: 5,55000 Euro
Volume: 35
Unit price: 5,55000 Euro
Volume: 50
Unit price: 5,55000 Euro
Volume: 200
Unit price: 5,55000 Euro
Volume: 1000
Unit price: 5,55000 Euro
Volume: 160
Unit price: 5,55000 Euro
Volume: 25
Unit price: 5,55000 Euro
Aggregated transactions
Volume: 6084
Volume weighted average price: 5.55952 Euro
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
[email protected]
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com